382.Cardiology's Blind Spot: Why Cardiac Intelligence Platforms Are Redefining Early Detection with Chris Darland, Peerbridge Health

In this episode, Omar Khateeb speaks with Chris Darland, President & CEO of Peerbridge Health, about the future of AI driven cardiac intelligence and preventive heart care. Peerbridge Health is building a platform designed to move cardiology from reactive intervention toward earlier detection through wearable ECG technology, software intelligence, and high fidelity cardiac data.Chris explains how most monitoring systems today focus mainly on arrhythmia detection, while Peerbridge is building toward a broader intelligence layer capable of identifying myocardial stress, structural defects, sleep related issues, and cardiac deterioration much earlier. The discussion also explores AI defensibility in MedTech, why proprietary data matters, how health systems could use intelligent triage tools to route patients faster, and why the future of cardiology may depend on scalable preventive infrastructure.This podcast is for informational and educational purposes only and does not constitute financial, investment, legal, or medical advice. The views and opinions expressed by hosts and guests are their own and do not necessarily reflect those of State of MedTech LLC. Nothing discussed on this podcast should be interpreted as a recommendation to buy, sell, or hold any investment or security. Listeners should conduct their own due diligence and consult with a qualified financial advisor, attorney, or other professional before making any financial or investment decisions.Episode Breakdown00:00 Why Cardiac Care is Still Reactive00:53 Intro + Chris Darland and Peerbridge Health02:00 Growing Up Around Heart Disease04:30 From GE to MedTech Startup CEO05:20 The Real Problem in Cardiology Today06:49 Scaling Cardiac Care Beyond Hospitals08:00 Heart Failure and Readmission Crisis09:00 Arrhythmia Monitoring Explained10:00 Beyond Arrhythmias: Structural Heart Detection12:00 AI + ECG for Earlier Detection13:58 Why Most MedTech Startups Fail After FDA14:05 Cardiac Intelligence Platform Explained16:00 Using ECG Data to Detect Heart Disease Early18:00 Why Signal Fidelity Matters19:30 AI Layer for Personalized Cardiac Insights23:00 Why Hardware + Unique Data Matter24:08 Regulatory Strategy and FDA Pathway27:30 NASA Signal Processing and SpaceTech Crossover29:15 Strategic Partnerships and Acquisition Potential31:00 Detecting Patients Before Critical Events33:35 AI Triage for Primary Care and Cardiology36:00 Reducing Unnecessary Specialist Visits37:39 Using AI to Route Patients to the Right Hospital39:00 Fundraising and Strategic Investors41:00 Clinical Trials and Real-World Evidence43:14 Early Trial Results and Heart Failure Detection44:09 The Future of AI-Powered Cardiac Care45:25 Why Mission Matters More Than Exit Price47:40 OutroAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channelhttps://www.youtube.com/@thestateofmedtechSubscribe to our LinkedIn Newsletterhttps://www.linkedin.com/newsletters/state-of-medtech-pod-7328860752952352770/Follow The State of MedTech onLinkedIn https://www.linkedin.com/company/thestateofmedtech/Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtechpodX https://x.com/stateofmedtechFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtechFollow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠TikTok https://www.tiktok.com/@omar.m.khateebX ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https: https://x.com/OmarMKhateebFacebook ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb#cardiology #medtech #aiinhealthcare #digitalhealth #healthcareinnovation